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Prevalence of psychotic symptoms in childhood and adolescence: 
a systematic review and meta-analysis of population-based studies 
 
Ian Kelleher*, Dearbhla Connor, Mary C. Clarke, Nina Devlin, Michelle Harley, Mary Cannon* 
 
 
Abstract 
BACKGROUND: Psychotic symptoms occur more frequently in the general population than psychotic disorder and index 
risk for psychopathology. Multiple studies have reported on the prevalence of these symptoms using self-report 
questionnaires or clinical interviews but there is a lack of consensus about the prevalence of psychotic symptoms among 
children and adolescents.  
METHOD: We conducted a systematic review of all published literature on psychotic symptom prevalence in two age 
groups, children (aged 9 to 12) and adolescents (aged 13 to 18), searching through electronic databases PUBMED, OVID 
MEDLINE, PsychINFO and EMBASE up to June 2011, and extracted prevalence rates. 
 RESULTS: We identified 19 population studies that reported on psychotic symptom prevalence among children and 
adolescents. The median prevalence of psychotic symptoms among children aged 9 to 12 was 17% and among adolescents 
aged 13 to 18 was 7.5%. 
CONCLUSIONS: Psychotic symptoms are relatively common in young people, especially in childhood. Prevalence is higher 
in younger (9 to 12 years) compared to older (13 to 18 years) children. 
 
INTRODUCTION 
 
The prevalence of psychotic symptoms in the general 
population greatly exceeds the prevalence of psychotic 
disorders. In the absence of illness, these symptoms are 
also sometimes referred to as psychotic experiences or 
psychotic-like experiences (PLEs) (Kelleher et al., 2010). 
A continuum between psychotic symptoms in childhood 
and psychotic disorder in adulthood was first 
demonstrated by Poulton et al. (2000) who showed that 
adolescents in a longitudinal birth cohort study who 
reported psychotic symptoms at age 11 were at a 5- to 
16-fold increased risk for psychotic disorder at age 26. 
Welham et al. (2009) subsequently also demonstrated 
that self-reported auditory hallucinations at age 14 
predicted increased rates of psychosis in adulthood. 
Individuals who report psychotic symptoms have also 
been demonstrated to share a wide range of risk factors 
with psychosis patients, including shared obstetric, 
developmental, substance use, social and environmental 
risk factors (for review, see Kelleher and Cannon, 2011). 
For these reasons, some researchers have argued that 
individuals who report psychotic symptoms represent a 
valid population in which to study the aetiology of 
psychosis (Linscott and van Os, 2010, Polanczyk et al., 
2010). More recently, evidence has been emerging that 
the clinical significance of psychotic symptoms extends 
beyond psychosis, with a number of research groups 
finding that young people who endorse questionnaire 
items on psychotic symptoms are also more likely to 
endorse symptoms of non-psychotic psychopathology, 
especially symptoms of depression (Hanssen et al., 
2003, Johns et al., 2004, Kelleher et al., In Press, Nishida 
et al., 2008, Polanczyk et al., 2010, Scott et al., 2009b, 
Varghese et al., 2011, Wigman et al., 2011, Yung et al., 
2009).  
 
A review of the general population prevalence of 
psychotic symptoms by van Os and colleagues up to 
2007 reported a median prevalence of 5% (van Os et al., 
2009). However, this meta-analysis was based mainly on 
adult studies. There has been no systematic review to 
date on the prevalence of psychotic symptoms 
specifically in childhood or adolescence. To address this 
issue, we carried out a systematic review and meta-
analysis of studies reporting prevalence rates for 
psychotic symptoms in the general population among 
children and adolescents up to age 18.  
 
 
METHOD 
Search Strategy 
We conducted a systematic review of all published 
literature on the prevalence of psychotic symptoms in 
children and adolescents. The methodology of this 
systematic review and meta-analysis followed the 
guidelines for conducting systematic reviews set out by 
AMSTAR (Shea et al., 2007). We searched through 
electronic databases PUBMED, OVID MEDLINE, 
PsychINFO and EMBASE from their inception to June 
2011 with the following search terms: young people, 
adolescents, teenagers, child / children, psychotic 
symptoms, psychosis, paranoia, delusions, 
hallucinations, grandiosity, unusual beliefs/ideations, 
positive and negative symptoms, prevalence and 
psychotic-like experiences. We searched using the 
format [(Young people OR adolescents OR teenagers OR 
child) AND (prevalence) AND (psychotic symptoms OR 
psychosis OR paranoia OR delusions OR hallucinations 
OR grandiosity OR unusual beliefs/ideations OR positive 
symptoms OR negative symptoms OR psychotic-like 
experiences)].We also searched references within 
papers to identify other possible studies.  
 
Inclusion Criteria  
 
Methods used to assess the prevalence of psychotic 
symptoms in studies to date include interviews and 
questionnaire surveys. The latter approach has involved 
a number of different questionnaires that have had a 
great deal of variance in terms of the number of 
questions asked (from 1 to 92 items). Furthermore, 
endorsement rates of more than 90% for ‘at least one 
psychotic symptom’ have been reported in 
questionnaire studies (Wigman et al., 2011), raising 
concerns about the validity of these items. 
Questionnaires have largely been unvalidated against 
clinical interview in terms of sensitivity and specificity 
and the inclusion of questionnaire studies risks 
overestimating the true prevalence of psychotic 
symptoms in the population. We recently showed, 
however, that some items on self-report questionnaire 
perform well in terms of identifying individuals with 
genuine psychotic symptoms when compared with gold 
standard clinical interview, while others perform poorly 
(Kelleher et al., 2011a). In particular, we found that a 
question on auditory hallucinations – “Have you ever 
heard voices or sounds that no one else can hear?” – 
demonstrated very good sensitivity, specificity and 
positive and negative predictive value not just for 
auditory hallucinations but for psychotic symptoms in 
general. Laurens et al. (2011) have also recently 
demonstrated, using item response theory analysis in a 
large population sample of children, that a self-report 
question on auditory hallucinations demonstrates the 
strongest psychometric properties for assessing the 
continuum of psychotic symptoms compared to other 
questions. For this reason, in addition to including 
psychotic symptom prevalence rates from interview 
studies, we included reports that used the same 
question as in our initial validation report (Kelleher et 
al., 2011a), or a question with a similar wording, in order 
to calculate a meta-analytic median prevalence of 
psychotic symptoms in studies of children and 
adolescents. 
 
Exclusion Criteria 
 
We excluded papers for the following reasons (a) did not 
report prevalence rates or data from which rates could 
be calculated, (b) did not report rates for individuals 
under 18 years or allow calculation of rates for this age 
group, (c) reported psychotic symptoms that were sleep 
related, substance use related or organic in origin only 
or (d) reported on clinical samples – that is 
inpatient/outpatient or help-seeking groups. 
 
Study selection and data extraction 
 
IK, DC, ND and MH independently conducted the 
searches and examined all titles and abstracts and 
assessed the relevance and appropriateness of the 
studies for the question under review. Full texts of 
potentially relevant papers were obtained. Where 
necessary, authors were contacted for further 
information. From each paper collected, IK and MCC 
extracted data on the age range of participants and the 
reported rates of psychotic symptoms. Where samples 
overlapped (e.g., publications on preliminary data), 
papers that reported on the largest overall sample size 
were used. 
 
Data Analysis 
Eligible studies were divided into two groups according 
to whether participants were aged 9 to 12 years (the 
child population) or aged 13 to 18 years (the adolescent 
population). Where studies cut across these age ranges, 
the mean age of participants was used to assign the 
study to the ‘childhood’ or the ‘adolescence’ group. We 
adopted the approach advocated by Saha et al., (2008) 
and also used in the previous psychotic symptom meta-
analysis conducted by van Os et al., (2009) to summarise 
rate data, reporting median prevalences for both age 
groups. 
 
RESULTS 
Our literature search yielded 3,597 papers. Titles and, as 
necessary, abstracts were read to determine articles of 
interest to the research question, yielding 199 papers. 
Of these, 26 (13%) had data on psychotic symptom 
prevalence in community samples of young people. 
Seven of these studies were excluded because they 
involved questionnaire surveys that did not contain a 
question of similar wording to the question chosen for 
the research protocol or because it was not possible to 
calculate the endorsement rate for such a question. A 
total of 19 studies met criteria for inclusion - 5 interview 
studies (Horwood et al., 2008, Kelleher et al., 2008, 
Kelleher et al., In Press, Polanczyk et al., 2010, Poulton 
et al., 2000) and 14 self report questionnaire studies 
(Barragan et al., 2011, De Loore et al., 2011, Dhossche et 
al., 2002, Kelleher et al., In Press, Kinoshita et al., 2011, 
Lataster et al., 2006, Laurens et al., 2011, Scott et al., 
2009a, Scott et al., 2009b, Wigman et al., 2011, 
Yoshizumi et al., 2004, Yung et al., 2009) (see Table 1). 
Prevalence rates were extracted from each study. The 
median prevalence of psychotic symptoms was 17% for 
the child population (ages 9 to 12 years), and 7.5% for 
the adolescent population (ages 13 to 18 years).  
 
DISCUSSION 
To our knowledge, this is the first systematic review to 
report on the prevalence of psychotic symptoms 
specifically in children and adolescents. A median of 17% 
of the childhood sample (9 to 12 years) reported 
psychotic symptoms, and 7.5% of the adolescent sample 
(13 to 18 years) reported psychotic symptoms. This 
compares to a median prevalence of 5% reported by van 
Os and colleagues in a meta analysis of mainly adult 
studies of psychotic symptoms, which supports the idea 
that psychotic symptoms are more prevalent in 
childhood compared to adulthood. This is also in line 
with longitudinal research, which has shown a decline in 
the incidence of psychotic symptoms in young people 
followed over time (Bartels-Velthuis et al., 2011, De 
Loore et al., 2011, Dominguez et al., 2011, Laurens et al., 
2011, Mackie et al., 2011). 
 
Our study has a number of strengths: firstly, we used an 
‘a priori’ design whereby our research question and 
inclusion criteria were formulated before the conduct of 
the review. Secondly, four independent researchers 
carried out the data searches and two independent 
researchers extracted the specific data. Our study is 
limited by the fact that we could not carry out a detailed 
assessment of bias at an individual study level. However, 
our use of a validated psychotic symptom assessment 
question used in all of the questionnaire studies helps us 
to control for quality of assessment across studies. The 
high amount of heterogeneity present across individual 
studies made the use of classical analytic techniques 
inappropriate, including meta-analytic methods of 
assessing for publication bias. 
N= 18 
 Hallucinations and delusions have typically been viewed 
as symptoms of psychosis and, in keeping with this, 
population research to date has largely considered these 
symptoms to represent a distributed risk for psychosis in 
the population (Polanczyk et al., 2010, van Os et al., 
2009). However, the relatively high prevalence of these 
symptoms would suggest a lack of specificity in terms of 
risk for psychosis. This is, in fact, in line with recent 
research, which suggests that psychotic symptoms 
reported both in the clinic and in the community index 
risk for a much wider range of psychopathology than 
psychotic disorders (Addington et al., 2011, Kelleher et 
al., 2011b, Lencz et al., 2004). Varghese et al., (2011), 
for example, reported an increased prevalence of 
psychotic symptoms among individuals who screened 
positive for depressive and anxiety disorders on the 
Composite International Diagnostic Interview. Rossler et 
al., (2011) have recently shown that psychotic 
symptoms at age 19 or 20 years predict a wide range of 
(non-psychotic) mental disorders in follow up studies 30 
years later. We have recently shown, using four 
population studies, that even in early adolescence the 
majority of individuals who report psychotic symptoms 
have at least one diagnosable (non-psychotic) Axis-1 
disorder (Kelleher et al., In Press). In fact, we found that 
psychotic symptoms indexed particularly high risk for 2 
or more co-occurring Axis-1 disorders in young people 
aged 11 to 16 years, suggesting that psychotic 
symptoms are important markers of risk for more severe 
psychopathology not limited to psychosis.  
 
Two recent studies suggest that age is an important 
factor in the relationship between psychotic symptoms 
and psychopathology. Bartels-Velthuis et al., (2010) 
found that auditory hallucinations in children aged 7 to 8 
years demonstrated only a minor association with 
psychopathology as measured by the Child Behavior 
Checklist (CBCL). However, when they reassessed these 
children at ages 12 to 13 years, they found that 
psychotic symptoms, whether persistent from childhood 
or newly incident, were strongly predictive of CBCL-
rated psychopathology (Bartels-Velthuis et al., 2011). 
We have recently shown that while psychotic symptoms 
are reported more commonly in early adolescent 
samples compared to middle adolescence, the 
relationship with psychopathology is stronger in middle 
adolescence (Kelleher et al., In Press). While 57% of a 
general population sample of 11 to 13 year olds who 
reported psychotic symptoms had a diagnosable Axis-1 
disorder, nearly 80% of a general population sample of 
13 to 15-year olds who reported psychotic symptoms 
had an Axis-1 disorder. Overall, these findings suggest 
that, while psychotic symptoms may form part of 
normal childhood development, they become 
increasingly abnormal (and indicative of pathology) with 
age. 
 
Research on the biological underpinnings of psychotic 
symptoms is still at an early stage. Alemany et al. (2011) 
recently documented the first allelic association with 
psychotic symptoms, demonstrating that persons 
exposed to childhood abuse who are Met carriers at the 
BDNF-Val66Met polymorphism are more likely to report 
psychotic symptoms, compared to persons who are Val 
homozygous. Magnetic resonance imaging research on 
adolescents with psychotic symptoms has demonstrated 
a number of anatomical and functional abnormalities, 
including in the cingulum and orbitofrontal cortex, while 
digital tractography imaging has revealed reduced 
integrity of fronto-temporal pathways (Jacobson et al., 
2010). Laurens and colleagues demonstrated executive 
functioning and verbal and working memory problems, 
as well as error-processing dysfunction in a sample of 
young adolescents who reported psychotic symptoms in 
combination with speech or motor developmental delay 
and emotional or behavioural problems (Cullen et al., 
2010, Laurens et al., 2010). Blanchard et al. (2010), 
meanwhile, demonstrated neurocognitive deficits in 
speed of processing as well as in tests of receptive 
language in adolescents with psychotic symptoms. 
Motor abnormalities have also been demonstrated by a 
number of studies, with dopamine dysregulation a 
suggested mechanism (Blanchard et al., 2010, 
MacManus et al., 2011, Mittal et al., 2011) Further work 
will be necessary in terms of neuro-genetics, imaging, 
electrophysiology and cognition to understand the ways 
in which psychotic symptoms contribute to a wide range 
of psychopathology in general and how these symptoms 
might contribute to psychosis in particular. 
 
Conclusion 
Psychotic symptoms are common in childhood and 
adolescence, with a median of 17% of 9 to 12 year olds 
and 7.5% of 13 to 18 year olds reporting symptoms. 
While an increased risk for psychosis is well established 
for young people who report psychotic symptoms 
(Poulton et al., 2000, Welham et al., 2009), recent 
research has highlighted the importance of these 
symptoms in relation to a wide variety of non-psychotic 
psychopathology, especially severe, comorbid Axis-1 
disorders (Kelleher et al., In Press, Rossler et al., 2011). 
Further work is necessary to understand the ways in 
which psychotic symptoms play a role in the aetiology of 
psychiatric illness.  
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